Related Experiment Video
Updated: Aug 7, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
[Antitumor activity of doxorubicin in respect to solid tumors in mice]
Abstract:
Antitumor activity of doxorubicin, an antibiotic prepared in the USSR was studied with respect to 4 solid tumors of mice: lymphosarcoma LIO-1, sarcoma 180, pregastric cancer OZh5 and melanoma B-16. Doxorubicin showed high antitumor activity against lymphosarcoma and sarcoma 180. However, it was somewhat lower than that of rubomycin and carminomycin. By selective antitumor activity against mouse pregastric cancer doxorubicin was superior to rubomycin and carminomycin. Estimation of antitumor activity of doxorubicin revealed its advantages in inhibition of melanoma B-16 growth, while carminomycin was superior in prolonging the animal life-span.
Insights
Doxorubicin exhibits significant antitumor effects against specific mouse cancers, showing high efficacy against lymphosarcoma and sarcoma 180. It also demonstrated selective activity against pregastric cancer and melanoma B-16.
Area of Science:
- Oncology
- Pharmacology
Background:
- Doxorubicin is an antibiotic developed in the USSR.
- Antitumor antibiotics like rubomycin and carminomycin are established treatments.
Purpose of the Study:
- To evaluate the antitumor activity of doxorubicin against four distinct solid mouse tumors.
- To compare doxorubicin's efficacy with existing agents, rubomycin and carminomycin.
Main Methods:
- In vivo study using mouse models.
- Assessment of tumor growth inhibition and animal survival rates.
- Testing against lymphosarcoma LIO-1, sarcoma 180, pregastric cancer OZh5, and melanoma B-16.
Main Results:
- Doxorubicin demonstrated high antitumor activity against lymphosarcoma LIO-1 and sarcoma 180.
- It showed superior selective antitumor activity against pregastric cancer OZh5 compared to rubomycin and carminomycin.
- Doxorubicin was more effective in inhibiting melanoma B-16 growth, whereas carminomycin prolonged animal lifespan.
Conclusions:
- Doxorubicin possesses significant antitumor properties against various mouse solid tumors.
- Its efficacy varies across tumor types, with notable activity against specific cancers.
- Doxorubicin presents a potentially valuable therapeutic option, with distinct advantages in certain cancer models.
More Related Videos
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
10:26Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017